Second Panel – Healthcare Economist

History and Future of the “ISPOR Value Flower”

2022-03-20Jason ShafrinLeave a comment

That is the name of a recent paper in Value in Health from three of pharmacoeconomics field’s leading scholars: Peter Neumann, Lou Garrison and Richard Wilke. The paper begins by comparing the ISPOR value flower against the recommendations from the Second Panel on Cost Effectiveness in Health and Medicine. Intervention types. The ISPOR Value Flower…

Future directions for cost effectiveness analysis research

2018-10-21Jason ShafrinLeave a comment

The Second Panel on Cost Effectiveness in Health and Medicine made a number of recommendations of how to improve cost effectiveness analysis (CEA). Yet, CEA is far from “solved”. In a recent article by Neumann et al. (2018), the Second Panel identifies seven CEA areas where additional research is needed. This include: CEA and perspective:…